Nordicus Partners (NORD) 8-K Advansource Biomaterials Announces Change In Auditors

EXHIBIT 16.1

March 31, 2009

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

Gentlemen:

We have read Item 4.01 of Form 8-K dated April 1, 2009, of AdvanSource Biomaterials Corporation and are in agreement with the statements contained in the second and third paragraphs therein. We have no basis to agree or disagree with other statements of the registrant contained therein.

/s/ Ernst & Young LLP